Ketamine Therapy for Psychosis: What You Need to Know

Psychosis can reshape your entire reality. Relationships feel strained, work becomes overwhelming, and distinguishing what's real from what isn't grows increasingly difficult.

If you're researching ketamine therapy for psychosis, you've likely heard about its success in treating depression and other mental health conditions. Ketamine can help treatment-resistant depression when nothing else works, but it isn't suitable for psychotic disorders— understanding why matters for your safety.

This guide explains what psychosis is, why ketamine poses specific risks for psychotic conditions despite helping other mental health disorders, and which evidence-based treatments can provide real relief when first-line options aren't enough.

What Is Psychosis?

Psychosis describes a collection of symptoms where someone becomes disconnected from reality. Schizophrenia, for example, the most well-known psychotic disorder, affects approximately 0.25-0.64% of the U.S. population. 

Globally, psychotic disorders impact 23 million people worldwide. Core symptoms fall into three categories:

Positive symptoms add experiences that weren't there before:

• Hallucinations (seeing, hearing, or sensing things that aren't present)
• Delusions (firmly held false beliefs)
• Disorganized speech and unusual behaviors

Negative symptoms take away normal experiences:

• Flattened emotional expression
• Decreased motivation and drive
• Social withdrawal and isolation

Cognitive difficulties impact daily functioning:

• Problems with reasoning and decision-making
• Memory issues
• Reduced ability to focus and process information

The most common psychotic disorders include schizophrenia, schizoaffective disorder (combining psychotic and mood symptoms), and brief psychotic disorder. These conditions rarely occur alone—half of individuals with schizophrenia also experience depression, and 45% have anxiety disorders.

Why Is Ketamine Therapy Not Recommended for Psychosis?

ketamine's mechanism of action directly conflicts with how psychotic disorders function in the brain. Ketamine works by blocking NMDA receptors. For depression, this promotes new neural connections and helps the brain form healthier pathways, but psychotic disorders are linked to NMDA receptor dysfunction. Blocking these receptors can intensify symptoms rather than relieve them.

Ketamine has been used as a model for schizophrenia since the 1960s because it reliably produces psychosis-like experiences in healthy volunteers. A JAMA Network Open review confirms that ketamine induces both positive and negative symptoms of schizophrenia—a key reason ketamine therapy for psychosis is not recommended.

The Ketamine Hydrochloride Monograph states clearly: Ketamine “may exacerbate schizophrenia; generally avoid use in patients with schizophrenia or active psychosis."

Why Is Psychosis a Contraindication for Ketamine?

Beyond the mechanism conflict, ketamine poses specific safety risks for people with psychotic disorders. Many clinical references and experts recommend avoiding ketamine in people with active psychosis or schizophrenia due to the risk of symptom exacerbation. 

The FDA issued a warning in October 2023 about compounded ketamine products, listing psychiatric events as a primary safety concern. Ketamine commonly causes dissociative states—feeling disconnected from yourself or your surroundings. If you already struggle with reality testing due to psychosis, these effects become indistinguishable from psychotic episodes. You can't tell if you're experiencing the effects of medication or a worsening of your condition.

Research also shows cognitive worsening rather than improvement in patients with schizophrenia following ketamine exposure.

Specifically, ketamine can cause or worsen symptoms, including:

• Hallucinations: intensifying or new ones emerging
• Stronger or more frequent delusions
• Increased disorganized thinking and speech
• Impaired reality testing
• Social cognition problems affecting relationships

Ketamine is also a Schedule III controlled substance with documented abuse potential. People with psychotic disorders have elevated rates of substance use disorders (approximately 50% lifetime co-occurrence).

What Treatments Actually Work for Psychosis?

In accordance with the guidelines set out by the American Psychiatric Association, most people with psychosis begin treatment with second-generation antipsychotics. These medications block dopamine receptors, reducing hallucinations, delusions, and disorganized thinking.

However, 20-30% of people with schizophrenia don't respond adequately to first-line treatment. If that's you, evidence-based alternatives do exist.

• Clozapine is specifically recommended for treatment-resistant schizophrenia by the American Psychiatric Association. While it requires regular blood monitoring, it helps many people who haven't responded to other medications.
• Long-acting injectable antipsychotics improve medication consistency and significantly reduce relapse risk compared to daily pills.
• Cognitive behavioral therapy for psychosis (CBTp) is strongly recommended by WHO and NICE guidelines for all adults with psychotic disorders, helping to manage symptoms, challenge distressing beliefs, and develop coping strategies.

Psychosocial services round out comprehensive care: case management, supported employment, social skills training, and family therapy all support long-term recovery.

What Conditions Can Ketamine Therapy Help With?

While ketamine isn't appropriate for psychotic disorders, it works remarkably well for other treatment-resistant mental health conditions.

Ketamine therapy has shown strong results for:

• Treatment-resistant depression: Response rates exceed 50%, with effects beginning within hours rather than weeks
• Anxiety disorders: Ketamine targets different brain pathways than traditional medications
• PTSD: Helps process traumatic memories when other treatments haven't worked
• Borderline personality disorder: Supports emotional regulation and stability

If you have one of these conditions and haven't found relief through standard care, ketamine therapy might offer the breakthrough you've been searching for. 

Learn more about whether ketamine therapy is right for you.

How Can Innerwell Support Your Mental Health Journey?

Innerwell provides at-home ketamine therapy for conditions where it's proven safe and effective, including treatment-resistant depression, anxiety disorders, and borderline personality disorder. Every potential patient undergoes a comprehensive psychiatric evaluation to ensure safety and appropriateness.

Innerwell's eligibility criteria explicitly exclude patients with psychosis or psychotic disorders from ketamine treatment. This isn't a limitation—it's a commitment to your safety.

If you have a psychotic disorder, Innerwell still offers traditional psychiatry and therapy services that include: 

• Medication management with qualified psychiatric providers
• Individual psychotherapy using evidence-based approaches
• Ongoing clinical support through a secure patient portal 

These services provide comprehensive mental health support tailored to your condition.

Take our free assessment to connect with Innerwell's clinical team about the right treatment path for your condition.

Frequently Asked Questions

Can ketamine ever be used safely with psychosis?

No. Medical guidelines and clinical research consistently show ketamine poses significant risks for people with psychotic disorders. Ketamine directly induces psychotic symptoms and has been used as a research model for schizophrenia. No clinical trial evidence supports its use for psychotic conditions.

Why does ketamine help depression but not psychosis?

Ketamine's NMDA receptor blocking mechanism helps depression by promoting new neural connections. However, psychotic disorders involve dysregulated NMDA function where blocking these receptors worsens rather than improves symptoms. The same mechanism that heals depression circuits triggers psychotic symptoms.

What should I try if standard antipsychotics aren't working?

Evidence-based alternatives include clozapine for treatment-resistant schizophrenia, cognitive behavioral therapy for psychosis (CBTp), long-acting injectable antipsychotics, and comprehensive psychosocial services including family therapy and case management. Innerwell's psychiatric team can help you explore which options fit your situation.

Are any psychedelic therapies being studied for psychosis?

Current psychedelic research focuses primarily on depression, PTSD, and anxiety disorders. Given that psychedelics can trigger psychotic episodes, research in psychotic disorders remains extremely limited with no large-scale trials establishing safety or efficacy.